Delivery Requirement: | Submission Compliance | ||||
Interim Financial Statements (Guarantor) | See Form 10-Q for the period ended 3/31/2023 as filed with the SEC. | ||||
Interim Financial Statements (Company) | Included herein | ||||
Compliance Certificates | Included herein for Guarantor and Company | ||||
Operating Statements a) Budget to Actual for the period b) Total product sold c) Amount of Product sold under offtake contracts (in total) and amount of other products sold (with information about sale/purchaser) d) Production Yield and values by weight/value e) Supplied waste processed by weight / values f) IHS/Chemical Data indices used g) Terms/ extensions / replacements of Offtake or Feedstock contracts h) Additional production capacity under development i) hours of operation for the Project | a) Refer to budget to actual b) Not applicable for Q1. There has been no product sold. c) Not applicable for Q1. There has been no product sold under Offtake Contracts or of other Products which require disclosure. d) Not applicable until production begins. e) Not applicable for Q1. f) Not applicable for pricing for Q1 g) None other than those previously disclosed. h) Not applicable. There have been no changes to production capacity. i) Not applicable for Q1. The plant will be operational during Q2. | ||||
Reconciliation Statements (Operating Revenue Fund) | Not applicable for Q1 as there have been no inflows or outflows from to/from the Operating Revenue Fund. |
Page | |||||
Unaudited Consolidated Financial Statements | |||||
Balance Sheets as of March 31, 2023 (Unaudited) and December 31, 2022 | 4 | ||||
Unaudited Statements of Operations for the Three months ended March 31, 2023 and 2022 | |||||
Unaudited Statements of Member's Equity for the Three months ended March 31, 2023 and 2022 | 6 | ||||
Unaudited Statements of Cash Flows for for the Three months ended March 31, 2023 and 2022 | |||||
Comparison of Actual to Budgeted Results for the Three months ended March 31, 2023 and 2022 | |||||
Covenant Compliance for the Three months ended March 31, 2023 |
ASSETS | ||||||||||||||
(Unaudited) | ||||||||||||||
(in thousands) | March 31, 2023 | December 31, 2022 | ||||||||||||
CURRENT ASSETS | ||||||||||||||
Cash | $ | 16,596 | $ | 50,928 | ||||||||||
Restricted cash - current | 53,786 | 29,389 | ||||||||||||
Prepaid expenses and other current assets | 3,216 | 1,612 | ||||||||||||
Total current assets | 73,598 | 81,929 | ||||||||||||
Restricted cash - non-current | 145,468 | 93,415 | ||||||||||||
Prepaid expenses and other non-current assets | 4,147 | 4,206 | ||||||||||||
Operating lease right-of-use assets | 5,277 | 5,042 | ||||||||||||
Property, plant and equipment, net | 422,465 | 373,848 | ||||||||||||
TOTAL ASSETS | $ | 650,955 | $ | 558,440 | ||||||||||
LIABILITIES AND MEMBER'S EQUITY | ||||||||||||||
CURRENT LIABILITIES | ||||||||||||||
Accounts payable | $ | 10,334 | $ | 816 | ||||||||||
Accrued expenses | 29,962 | 26,715 | ||||||||||||
Accrued interest | 6,127 | 1,532 | ||||||||||||
Total current liabilities | 46,423 | 29,063 | ||||||||||||
NON-CURRENT LIABILITIES | ||||||||||||||
Deferred revenue | 5,000 | 5,000 | ||||||||||||
Bonds payable - non-current | 233,778 | 233,513 | ||||||||||||
Operating lease right-of-use liabilities | 4,157 | 3,956 | ||||||||||||
Other non-current liabilities | 1,068 | 1,117 | ||||||||||||
Due to parent | 270,412 | 188,989 | ||||||||||||
TOTAL LIABILITIES | $ | 560,838 | $ | 461,638 | ||||||||||
MEMBER'S EQUITY | ||||||||||||||
LLC Member Interest | 223,387 | 223,387 | ||||||||||||
Accumulated deficit | (133,270) | (126,585) | ||||||||||||
TOTAL MEMBER'S EQUITY | 90,117 | 96,802 | ||||||||||||
TOTAL LIABILITIES AND MEMBER'S EQUITY | $ | 650,955 | $ | 558,440 |
Three months ended March 31, | ||||||||||||||
2023 | 2022 | |||||||||||||
(in thousands) | ||||||||||||||
Costs and expenses | ||||||||||||||
Operating costs | $ | 4,524 | $ | 2,916 | ||||||||||
Research and development | 307 | 293 | ||||||||||||
Selling, general and administrative | 2,624 | 1,701 | ||||||||||||
Total operating costs and expenses | 7,455 | 4,910 | ||||||||||||
Interest (income) expense | (819) | 564 | ||||||||||||
Other expense | 49 | 6 | ||||||||||||
Total other (income) expenses | (770) | 570 | ||||||||||||
Net loss | $ | (6,685) | $ | (5,480) |
For the three months ended March 31, 2023 | ||||||||||||||||||||
(in thousands) | LLC Member Interest | Accumulated deficit | Total Member's Equity | |||||||||||||||||
Balance, December 31, 2022 | $ | 223,387 | $ | (126,585) | $ | 96,802 | ||||||||||||||
Net Loss | — | (6,685) | (6,685) | |||||||||||||||||
Balance, March 31, 2023 | $ | 223,387 | $ | (133,270) | $ | 90,117 | ||||||||||||||
For the three months ended March 31, 2022 | ||||||||||||||||||||
(in thousands) | LLC Member Interest | Accumulated deficit | Total Member's Equity | |||||||||||||||||
Balance, December 31, 2021 | $ | 223,387 | $ | (104,276) | $ | 119,111 | ||||||||||||||
Net Loss | — | (5,480) | (5,480) | |||||||||||||||||
Balance, March 31, 2022 | $ | 223,387 | $ | (109,756) | $ | 113,631 |
Three months ended March 31, | ||||||||||||||
(in thousands) | 2023 | 2022 | ||||||||||||
Cash flows from operating activities | ||||||||||||||
Net loss | $ | (6,685) | $ | (5,480) | ||||||||||
Adjustments to reconcile net loss to net cash used in operating activities | ||||||||||||||
Depreciation expense | 827 | 768 | ||||||||||||
Accretion of debt instrument discounts | 62 | 58 | ||||||||||||
Amortization of debt issuance costs | 202 | 187 | ||||||||||||
Operating lease amortization expense | 338 | 17 | ||||||||||||
Changes in operating assets and liabilities | ||||||||||||||
Prepaid expenses and other current assets | (1,603) | (683) | ||||||||||||
Prepaid expenses and other non-current assets | 59 | — | ||||||||||||
Accounts payable | 967 | 611 | ||||||||||||
Accrued expenses | 206 | 375 | ||||||||||||
Accrued interest | 324 | 324 | ||||||||||||
Operating lease right-of-use liabilities | (176) | (17) | ||||||||||||
Net cash used in operating activities | $ | (5,479) | $ | (3,840) | ||||||||||
Cash flows from investing activities | ||||||||||||||
Purchases of property, plant and equipment | (33,786) | (47,364) | ||||||||||||
Net cash used in investing activities | $ | (33,786) | $ | (47,364) | ||||||||||
Cash flows from financing activities | ||||||||||||||
Due to Parent | 81,423 | 100,126 | ||||||||||||
Other payments from financing activities | (40) | (10) | ||||||||||||
Net cash provided by financing activities | $ | 81,383 | $ | 100,116 | ||||||||||
Net increase in cash and restricted cash | 42,118 | 48,912 | ||||||||||||
Cash and restricted cash, beginning of year | 173,732 | 330,574 | ||||||||||||
Cash and restricted cash, end of year | $ | 215,850 | $ | 379,486 | ||||||||||
Supplemental disclosure of cash flow information | ||||||||||||||
Non-cash investing activities: | ||||||||||||||
Additions to property, plant, and equipment in accounts payable | $ | 9,066 | $ | 224 | ||||||||||
Additions to property, plant, and equipment in accrued interest | $ | 4,271 | $ | 4,271 | ||||||||||
Additions to property, plant, and equipment in accrued expenses | $ | 27,766 | $ | 13,871 |
For the Quarter Ended March 31, 2023 | |||||||||||||||||||||||||||||
Actual | Budget | $ Variance | % Variance | Explanations | |||||||||||||||||||||||||
(in thousands) | favorable / (unfavorable) | ||||||||||||||||||||||||||||
Costs and expenses | |||||||||||||||||||||||||||||
Operating costs | $ | 4,524 | $ | 4,174 | $ | (350) | (8) % | ~$240k in professional services incurred related to commissioning the plant and LLC stand alone audit fees not included in budget ~$215k related to maintenance tools and supplies (one time costs) Overage partially offset by ~ $165k favorable related to employee costs resulting from shifts in the hiring plan | |||||||||||||||||||||
Research and development | 307 | 40 | (267) | (666) % | Overage driven primarily by additional feedstock testing performed by third-parties (e.g. Phasex, GALAB, etc.) | ||||||||||||||||||||||||
Selling, general and administrative | 2,624 | 417 | (2,207) | (530) % | ~$700k of legal fees paid to the Trustee's counsel ~$1.5M in corporate overhead allocation for shared services; allocation of some costs required under GAAP | ||||||||||||||||||||||||
Total operating costs and expenses | 7,455 | 4,631 | (2,824) | (61) % | |||||||||||||||||||||||||
Interest (income) expense | $ | (819) | $ | 590 | $ | 1,409 | 239 % | ~$997k of interest income on bond and escrow accounts partially offset by interest expense of ~$327k ~$140k net debt related amortization not included in the budget | |||||||||||||||||||||
Other expense | 49 | — | (49) | 100 % | immaterial for review | ||||||||||||||||||||||||
Total other (income) expense | $ | (770) | $ | 590 | $ | 1,360 | 230 % | ||||||||||||||||||||||
Net loss | $ | (6,685) | $ | (5,221) | $ | (1,464) | (28) % |
Days Cash on Hand: >75 | As of March 31, 2023 | |||||||
Cash on Hand1 | $ | 66,597 | ||||||
Operating Expenses2 | (6,628) | |||||||
Debt Service for Period3 | — | |||||||
Total Operating Expenses + Debt Service | $ | (6,628) | ||||||
Daily Cash Required4 | $ | 74 | ||||||
Days Cash on Hand | 904 | pass |
Minimum Cash Required (at least $100M) | As of March 31, 2023 | |||||||
Cash & cash equivalents | $ | 16,596 | ||||||
Liquidity Escrow Reserve | 50,796 | |||||||
PureCycle Trustee Account | 50,000 | |||||||
Operating Revenue Escrow Fund | 1 | |||||||
Total Cash | $ | 117,393 | pass |